LEADER 03906nam  2201129z- 450 
001 9910557585603321
005 20240107231711.0
035   $a(CKB)5400000000043792
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69064
035   $a(EXLCZ)995400000000043792
100   $a20202105d2020      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aStroke, Dementia and Atrial Fibrillation
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020
215   $a1 electronic resource (212 p.)
311   $a3-03936-672-6 
311   $a3-03936-673-4 
330   $aThe present special issue will lead you to discover the association between cerebrovascular events, cognitive impairment and atrial fibrillation, through update reviews and original articles exploring the pathophysiological mechanisms underpinning this association and describing the latest results in term of stroke prevention in AF. An interesting scientific journey that reflects the recent advances in pharmacological treatments and interventional procedures involving both mind and heart.
606   $aMedicine$2bicssc
610   $amemory loss
610   $aantioxidant
610   $aneuroprotective
610   $aacetylcholinesterase inhibitor
610   $amolecular docking
610   $aatrial
610   $afibrillation
610   $avenous
610   $athrombosis
610   $aanticoagulation
610   $aperception
610   $achronic obstructive pulmonary disease
610   $aatrial fibrillation
610   $acardiovascular risk
610   $aoutcome
610   $aprognosis
610   $anovel oral anticoagulants
610   $aprosthetic valve replacement
610   $asubclinical atrial fibrillation
610   $astroke
610   $aischemic cerebral events
610   $acatheter ablation
610   $ascreening
610   $acognitive impairment
610   $aatrial fibrillation ablation
610   $aiatrogenic interatrial septum defect
610   $aparadoxical embolism
610   $aanticoagulant interruption
610   $acardioversion
610   $aoral anticoagulation therapy
610   $aleft atrial appendage thrombosis
610   $atransesophageal echocardiography
610   $aIL1B
610   $aIL1RN
610   $apolymorphism
610   $ainflammation
610   $acognitive decline
610   $arhythm control
610   $amicrobleeds
610   $acerebral ischemia
610   $adiabetes mellitus
610   $ametformin
610   $athiazolidinediones
610   $aGLP-1 receptor agonists
610   $aSGLT-2 inhibitors
610   $aatrial high rate episodes
610   $aNOACs
610   $anon vitamin K oral anticoagulants
610   $aoral anticoagulation
610   $aintracerebral hemorrhage
610   $acerebral small vessel disease
610   $abrain MRI
610   $acirculating biomarkers
610   $adirect oral anticoagulants (DOACs)
610   $aatrial fibrillation (AF)
610   $aelectrical cardioversion (EC)
610   $asurgical cryoablation
610   $aleft atrial function
610   $aminimally invasive mitral valve repair
610   $aechocardiography
610   $aaneurysmal subarachnoid hemorrhage
610   $ainterdisciplinary setting
610   $ametabolic syndrome
610   $aobesity
610   $adementia
615  7$aMedicine
700   $aRusso$b Vincenzo$4edt$0191358
702   $aProietti$b Riccardo$4edt
702   $aRusso$b Vincenzo$4oth
702   $aProietti$b Riccardo$4oth
906   $aBOOK
912   $a9910557585603321
996   $aStroke, Dementia and Atrial Fibrillation$93038530
997   $aUNINA